Literature DB >> 21849177

Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.

Bianca Weinstock-Guttman1, Robert Zivadinov, Murali Ramanathan.   

Abstract

OBJECTIVE: To assess whether vitamin D (VD) levels in multiple sclerosis (MS) patients exhibit inter-dependence with serum lipid profile variables (serum cholesterol, high-density lipoprotein or HDL, low-density lipoprotein or LDL, and triglycerides) and to investigate the associations with clinical disability measures.
METHODS: The study population consisted of consecutive 178 MS patients (age: 46.6±10.6 years; disease duration: 13.8±10.3 years). The patients were assessed for fasting lipid profile and VD obtained concomitantly. Neurological disability using the Expanded Disability Status Scale (EDSS) was obtained within ±6 months of the lipid profile. The associations between the HDL, LDL, total cholesterol and total cholesterol to HDL ratio with deseasonalized VD levels and their relationships with EDSS and the MS Severity Score (MSSS) were analyzed using regression methods.
RESULTS: The cholesterol to HDL ratio was associated with the deseasonalized VD (r(p)=-0.18, p=0.019) and VD3 (r(p)=-0.17, p=0.028) levels. The probability of VD3 sufficiency was associated with HDL>60 mg/dl status (p=0.015, OR=0.42, 95% CI=0.20 to 0.86) and with total cholesterol to HDL ratio<3.5 status (p<0.001, OR=4.07, 95% CI=2.03 to 8.15). In stepwise regression models, EDSS was associated with total cholesterol to HDL ratio (p=0.008, r(p)=0.21) whereas MSSS was associated with deseasonalized 25-hydroxy VD3 (p=0.021, r(p)=-0.18). The probability of EDSS≥4.0 was also associated with total cholesterol to HDL ratio (p=0.011, OR=1.59, 95% CI=1.11 to 1.26).
CONCLUSIONS: The results suggest inter-dependence between the total cholesterol to HDL ratio and deseasonalized vitamin D levels in MS patients. Disability measures in MS are also associated with these inter-dependent variables.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849177     DOI: 10.1016/j.jns.2011.07.024

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS.

Authors:  Bianca Weinstock-Guttman; Murali Ramanathan
Journal:  Nat Rev Neurol       Date:  2012-01-10       Impact factor: 42.937

2.  Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.

Authors:  Jana Figurová; Ingrid Dravecká; Martin Javorský; Jana Petríková; Ivica Lazúrová
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

Review 3.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

4.  What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?

Authors:  Linn H Steffensen; Magritt Brustad; Margitta T Kampman
Journal:  J Neurol       Date:  2012-08-01       Impact factor: 4.849

5.  Lipid status association with 25-hydroxy vitamin D: Cross sectional study of end stage renal disease patients.

Authors:  Neda Milinković; Marija Sarić; Snežana Jovičić; Duško Mirković; Višnja Ležaić; Svetlana Ignjatović
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

6.  HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.

Authors:  Victoria A Blaho; Sylvain Galvani; Eric Engelbrecht; Catherine Liu; Steven L Swendeman; Mari Kono; Richard L Proia; Lawrence Steinman; May H Han; Timothy Hla
Journal:  Nature       Date:  2015-06-08       Impact factor: 49.962

7.  Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS.

Authors:  Rohini Narayanaswamy; Vignesh Iyer; Prachi Khare; Mary Lou Bodziak; Darlene Badgett; Robert Zivadinov; Bianca Weinstock-Guttman; Todd C Rideout; Murali Ramanathan; Richard W Browne
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  Impact of Nutritional Intake on Function in People with Mild-to-Moderate Multiple Sclerosis.

Authors:  Lacey Bromley; Peter J Horvath; Susan E Bennett; Bianca Weinstock-Guttman; Andrew D Ray
Journal:  Int J MS Care       Date:  2019 Jan-Feb

9.  Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study.

Authors:  Dana Horakova; Robert Zivadinov; Bianca Weinstock-Guttman; Eva Havrdova; Jun Qu; Miriam Tamaño-Blanco; Darlene Badgett; Michaela Tyblova; Niels Bergsland; Sara Hussein; Laura Willis; Jan Krasensky; Manuela Vaneckova; Zdenek Seidl; Petra Lelkova; Michael G Dwyer; Ming Zhang; Haoying Yu; Xiaotao Duan; Tomas Kalincik; Murali Ramanathan
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.